Sign in

Private company

Notable Labs, Ltd.

Notable Labs, Ltd. is a pharmaceutical preparations company.1 It is headquartered in Foster City, California.1

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersFoster City, California1
  • Incorporated inIsrael2
  • Business address320 Hatch Drive, Foster City, Ca 944042
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Notable continuing after the merger as the surviving entity and a wholly owned subsidiary of the Company (the “Merger”).3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

36.5%Gross margin4
-4728.1%Operating margin4
-3633.5%Net margin4
3775.0%Revenue growth, 20234
-74.5%Return on equity4
-$13.8MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue4¢$197.0K
  • Research and development96¢$4.7M

Out of $310.0K in revenue.4 The company lost money this year.

Financial statements

Revenue56784$310.0K in 2023−98% since 2017
0$5.0M$10.0M$15.0M2017: $13.9M$13.9M20172018: $585.0K$585.0K2018−96%2019: $562.0K$562.0K2019−4%2020: $922.0K$922.0K2020+64%2021: $768.0K$768.0K2021−17%2022: $8.0K$8.0K2022−99%2023: $310.0K$310.0K2023+3775%
Gross profit56784$113.0K in 2023−99% since 2017
0$5.0M$10.0M$15.0M2017: $13.5M$13.5M20172018: $330.0K$330.0K2018−98%2019: $340.0K$340.0K2019+3%2020: $528.0K$528.0K2020+55%2021: $403.0K$403.0K2021−24%2022: $8.0K$8.0K2022−98%2023: $113.0K$113.0K2023+1312%
Operating income56784-$14.7M in 2023
-$40.0M-$20.0M0$20.0M$40.0M2017: $10.1M$10.1M20172018: $21.2M$21.2M2018+110%2019: -$20.1M-$20.1M20192020: -$24.5M-$24.5M2020+22%2021: -$30.0M-$30.0M2021+23%2022: -$12.9M-$12.9M2022−57%2023: -$14.7M-$14.7M2023+13%
Net income6784-$11.3M in 2023
-$40.0M-$20.0M0$20.0M$40.0M2018: $20.5M$20.5M20182019: -$19.4M-$19.4M20192020: -$24.2M-$24.2M2020+25%2021: -$29.9M-$29.9M2021+24%2022: -$14.4M-$14.4M2022−52%2023: -$11.3M-$11.3M2023−22%
Fiscal year2017201820192020202120222023
Revenue$13.9M5$585.0K6$562.0K7$922.0K7$768.0K8$8.0K4$310.0K4
Cost of revenue$255.0K6$222.0K7$394.0K7$365.0K8$104.0K8$197.0K4
Gross profit$13.5M5$330.0K6$340.0K7$528.0K7$403.0K8$8.0K4$113.0K4
Research and development$15.2M6$14.7M7$19.7M7$22.7M8$7.8M4$4.7M4
Operating expenses$12.9M4$14.8M4
Operating income$10.1M5$21.2M6-$20.1M7-$24.5M7-$30.0M8-$12.9M4-$14.7M4
Interest$159.0K6$184.0K7$105.0K7$44.0K8$85.0K8
Net income$20.5M6-$19.4M7-$24.2M7-$29.9M8-$14.4M4-$11.3M4
Earnings per share$0.458-$21.974-$3.414
Earnings per share (diluted)-$21.974-$3.414
Shares (weighted, basic)66.3M shares8655.7K shares43.3M shares4
Shares (weighted, diluted)655.7K shares43.3M shares4

Compare Notable Labs, Ltd. with another company

Corporate structure

Notable Labs, Ltd. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Notable Labs, Ltd.

  • Notable Labs, Ltd. Foster City, California

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Notable Labs, Ltd. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$2.3M4 Dec 31, 2023$2.2M4 Dec 31, 2022+3.1%
Accumulated depreciation$2.0M4 Dec 31, 2023$1.8M4 Dec 31, 2022+11.0%
Property and equipment, net$316.0K4 Dec 31, 2023$442.0K4 Dec 31, 2022−28.5%
Finance-lease assets$337.0K4 Dec 31, 2023
Operating-lease assets (leased space)$1.7M4 Dec 31, 2023$357.0K4 Dec 31, 2022+374.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$11.8M4 Dec 31, 2023$1.6M4 Dec 31, 2022+647.9%

Leadership

Who has led Notable Labs, Ltd., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Dror Harats2023
  2. Thomas Bock2023–2024
  3. Kaile A. Zagger2024

Chief financial officer

  1. Samuel Backenroth2023
  2. Scott Alan McPherson2023
2025
Board members and other officers (13)

Former names

  • Vascular Biogenics Ltd.Mar 25, 2014 to Oct 12, 20232

Timeline

  1. Oct 16, 20248-K Listing notice or transfer29
  2. Oct 15, 20248-K Bankruptcy or receivership; Executive or director change30
  3. Sep 26, 2024New chief executive Kaile A. Zagger becomes CEO13
  4. Sep 19, 20248-K Exit or restructuring costs31
  5. Sep 16, 20248-K Executive or director change32
  6. Aug 26, 20248-K Executive or director change; Regulation FD disclosure33
  7. Aug 6, 20248-K Regulation FD disclosure34
  8. Jul 24, 20248-K Other events35
  9. Jul 19, 20248-K Listing notice or transfer36
  10. May 30, 20248-K Regulation FD disclosure37
  11. May 6, 20248-K Regulation FD disclosure38
  12. Apr 12, 20248-K Results of operations39
  13. Apr 9, 20248-K Other events40
  14. Oct 18, 2023New chief executive Thomas Bock becomes CEO15
  15. Jan 3, 2023New chief executive Dror Harats becomes CEO14

Calendar

When it reported results

  1. Apr 12, 2024Reported quarterly or annual results39
  2. Nov 14, 2023Reported quarterly or annual results41
  3. Aug 14, 2023Reported quarterly or annual results42
  4. May 15, 2023Reported quarterly or annual results43
  5. Mar 14, 2023Reported quarterly or annual results44
  6. Feb 23, 2023Reported quarterly or annual results45

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

157 filings to the SEC since October 2021: 3 annual reports, 5 quarterly reports, 37 major events, 37 insider forms, 8 large holders, 67 other. The latest 20:

  1. Aug 18, 2025SEC STAFF ACTION EDGAR
  2. Oct 16, 20248-K EDGAR
  3. Oct 15, 20248-K EDGAR
  4. Sep 26, 20243 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  5. Sep 19, 20248-K EDGAR
  6. Sep 16, 20248-K EDGAR
  7. Aug 29, 2024S-1/A EDGAR
  8. Aug 26, 2024S-1/A EDGAR
  9. Aug 26, 20248-K EDGAR
  10. Aug 14, 202410-Q EDGAR
  11. Aug 9, 2024SC 13D/A EDGAR
  12. Aug 6, 20248-K EDGAR
  13. Jul 24, 20248-K EDGAR
  14. Jul 19, 20248-K EDGAR
  15. Jul 1, 2024S-1/A EDGAR
  16. Jun 20, 2024S-1 EDGAR
  17. May 30, 20248-K EDGAR
  18. May 15, 202410-Q EDGAR
  19. May 10, 20244 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  20. May 10, 20244 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR

The 157 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

7 open-market trades by officers, directors and large owners since October 2021: 0 buys and 7 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jan 2, 2024FR Capital Holdings, L.P.Sale50,000$1.89$94.5KForm 4
Dec 29, 2023FR Capital Holdings, L.P.Sale6,000$1.83$11.0KForm 4
Dec 28, 2023FR Capital Holdings, L.P.Sale21,500$2.01$43.2KForm 4
Dec 27, 2023FR Capital Holdings, L.P.Sale20,033$2.08$41.7KForm 4
Dec 26, 2023FR Capital Holdings, L.P.Sale11,456$2.16$24.7KForm 4
Dec 22, 2023FR Capital Holdings, L.P.Sale45,000$2.41$108.5KForm 4
Dec 21, 2023FR Capital Holdings, L.P.Sale2,867$2.51$7.2KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$1.8M 2020–2021
Money received by yearMoney received by year, 2020–2021: $1.8M in all. PPP loans $1.8M.$0$500K$1M$1.5M2020 · PPP loans: $765.1K20202021 · PPP loans: $1.0M2021
Figures by year
YearPPP loansTotal
2021$1.0M$1.0M
2020$765.1K$765.1K

PPP loans

Paycheck Protection Program loans of $150,000 and up, approved April 2020 to July 2021, from the SBA53. Matched to this company by name and state.

  1. Apr 12, 2020$765.1K PPP loan (first draw) from Silicon Valley Bridge Bank NA53To NOTABLE LABS, INC, Foster City CA; $770.9K forgiven Jan 25, 2021
  2. Feb 6, 2021$1.0M PPP loan (second draw) from Silicon Valley Bridge Bank NA53To NOTABLE LABS INC., Foster City CA; $1.0M forgiven Mar 2, 2022

SEC filer profile

How Notable Labs, Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARNotable Labs, Ltd.1
  • CIK0001603207
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inIsrael1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address320 Hatch Drive, Foster City, CA 944041
  • Phone415-851-24101
  • Shares outstanding9,659,496 as of Aug 14, 202410
  • Public float$15.8M as of Jun 30, 20234
  • On EDGAR sinceMar 25, 20141
  • Filings355 in all: 6-K (106), 8-K (35), 3 (20), 4 (18), 425 (16), CORRESP (15), UPLOAD (14), 424B5 (12)1
    All 47 form types

    SC 13G (12), SC 13G/A (10), 20-F (8), EFFECT (8), S-8 (8), SC 13D/A (6), 10-Q (5), 424B3 (5), 6-K/A (5), S-4/A (5), F-1/A (4), CT ORDER (3), F-3 (3), S-1/A (3), 10-K (2), 424B4 (2), 8-K/A (2), DRS/A (2), F-1 (2), FWP (2), POS AM (2), SC 13D (2), SEC STAFF LETTER (2), 20-F/A (1), 25-NSE (1), 424B8 (1), 8-A12B (1), ARS (1), CERTNAS (1), DEF 14A (1), DRS (1), F-3/A (1), NT 10-K (1), PRE 14A (1), RW (1), S-1 (1), S-3 (1), S-4 (1), SEC STAFF ACTION (1)

  • Latest filingsAnnual report (10-K) Apr 11, 2024
    Quarterly report (10-Q) Aug 14, 2024
    Proxy statement (DEF 14A) Feb 16, 2024
    Latest 8-K (8-K) Oct 16, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
    SEC EDGAROther events
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
    SEC EDGAROther events
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53